Managing Antimicrobial Resistance in the Emergency Department.

Autor: Yeary J; Department of Pharmacy, Barnes Jewish Hospital, 1 Barnes Jewish Place, St Louis, MO 63110, USA. Electronic address: julianne.yeary@bjc.org., Hacker L; Department of Pharmacy, UW Health, 600 Highland Avenue, Madison, WI 53792, USA., Liang SY; Department of Emergency Medicine and Division of Infectious Diseases, John T. Milliken Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Jazyk: angličtina
Zdroj: Emergency medicine clinics of North America [Emerg Med Clin North Am] 2024 May; Vol. 42 (2), pp. 461-483. Date of Electronic Publication: 2024 Mar 15.
DOI: 10.1016/j.emc.2024.02.005
Abstrakt: (Basic awareness and understanding of antimicrobial resistance and prevailing mechanisms can aid emergency physicians in providing appropriate care to patients with infections due to a multidrug-resistant organism (MDRO). Empiric treatment of MDRO infections should be approached with caution and guided by the most likely pathogens based on differential diagnosis, severity of the illness, suspected source of infection, patient-specific factors, and local antibiotic susceptibility patterns. Newer broad-spectrum antibiotics should be reserved for critically ill patients where there is a high likelihood of infection with an MDRO.).
Competing Interests: Disclosure The authors report no conflicts of interest or funding relevant to the preparation of this article. SYL received support through the Foundation for Barnes-Jewish Hospital, United States and the Washington University Institute of Clinical and Translational Sciences which is, in part, supported by the NIH, United States/National Center for Advancing Translational Sciences (NCATS), Clinical and Translational Science Award (CTSA) program (UL1TR002345).
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE